Traditional molecular PCR testing requires a large analyzer in a central laboratory, supplied with reagents or cartridges and operated by skilled lab professionals. For highly accurate and reliable diagnostic results, the healthcare professional has had only two choices:

• Send the collected patient sample to a central/remote PCR lab for batch processing, with turnaround time from hours to days, or
• Invest in point-of-care instrumentation that can bring the test closer, but with instrument bottlenecks, downtime and ongoing expenses for maintenance, calibration and cartridges.

This problem means patients may not get the treatment or the right treatment – which often leads to unnecessary use of antibiotics and antimicrobial resistance, expedited partner treatment cannot be initiated, and patients are often lost to follow-up. When patients leave without the right treatment, the infection continues to spread in them and possibly to their partner(s) and throughout the community.

This webinar will present the 2021 CDC STI guidelines, dive into the challenges with traditional STI testing and the impact on antibiotic stewardship and review what is needed to combat the growing number of antibiotic resistant STI.